CG Oncology, Inc. (CGON) has 5 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $24.8M. Most recent filing: Aug. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 18, 2026 filed Aug. 14, 2026 | POST LEONARD E Director | $73,940 | 3,000 | 0% | Yes | |
|
|
||||||
| July 17, 2026 filed July 15, 2026 | POST LEONARD E Director | $70,570 | 3,000 | 0% | Yes | |
|
|
||||||
| July 14, 2026 filed July 10, 2026 | Mulay James Director | $1,172,727 | 72,495 | — | Yes | |
|
|
||||||
| June 29, 2026 filed June 25, 2026 | Liu Brian Guan-Chyun Director | +$24,814,454 | 371,085 | +24% | Yes | |
|
|
||||||
| June 25, 2026 filed June 24, 2026 | POST LEONARD E Director | $347,000 | 15,000 | 0% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free